| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |